ASAIO Journal 2011-01-01

A crossover study of the acrylonitrile-co-methallyl sulfonate and polysulfone membranes for elderly hemodialysis patients: the effect on hemodynamic, nutritional, and inflammatory conditions.

Minoru Furuta, Takahiro Kuragano, Aritoshi Kida, Rie Kitamura, Masayoshi Nanami, Yoshinaga Otaki, Hiroshi Nonoguchi, Akihide Matsumoto, Takeshi Nakanishi

Index: ASAIO J. 57(4) , 293-9, (2011)

Full Text: HTML

Abstract

Many maintenance hemodialysis (MHD) patients have recently been treated with high flux (HF) dialysis membranes such as polysulfone (PSu) membranes. However, the appropriateness of HF for elderly MHD remains to be elucidated. In order to estimate hemodialysis (HD) efficiency, the hemodynamic condition during HD, and the nutritional status, 28 elderly MHD patients were treated with PSu for 3 months. After this, the patients were switched to acrylonitrile-co-methallyl sulfonate (AN69) membranes for the next 3 months and then returned to PSu for another 3 months. Reduction ratio of inflammatory cytokines (interleukin [IL]-6) by AN69 was significantly higher than the reduction ratio by PSu. After 3 months with AN69, the serum total protein, albumin, and cholesterol levels significantly increased, and after switching back to PSu, the levels returned to baseline. Furthermore, the frequency of saline used to treat episodes of hypotension during HD significantly decreased in the AN69 period. In elderly MHD patients, it was possible to achieve improvements in both malnutrition and chronic inflammatory conditions with AN69. This suggests that AN69 may be the preferred membrane for elderly MHD, because it stabilizes the hemodynamic condition and demonstrates a higher removal of inflammatory cytokines during HD.


Related Compounds

Related Articles:

Behaviour of fibroblasts on water born acrylonitrile-based copolymers containing different cationic and anionic moieties.

2012-01-01

[Clin. Hemorheol. Microcirc. 52(2-4) , 295-311, (2012)]

Biocompatibility of hemodialysis membranes: a study in healthy subjects.

1994-01-01

[Blood Purif. 12(2) , 95-105, (1994)]

Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients.

2005-11-01

[J. Clin. Pharmacol. 45(11) , 1294-304, (2005)]

Hemodialysis membrane biocompatibility: the case of erythropoietin.

1991-01-01

[Blood Purif. 9(3) , 153-63, (1991)]

Toxicity and uptake potential of an acrylic polymer comonomer and its biological degradation products.

1988-03-01

[Bull. Environ. Contam. Toxicol. 40(3) , 325-31, (1988)]

More Articles...